Your browser doesn't support javascript.
loading
Subproteome of Lachesis muta rhombeata venom and preliminary studies on LmrSP-4, a novel snake venom serine proteinase
Wiezel, Gisele A; Bordon, Karla C. F; Silva, Ronivaldo R; Gomes, Mário S. R; Cabral, Hamilton; Rodrigues, Veridiana M; Ueberheide, Beatrix; Arantes, Eliane C.
Afiliação
  • Wiezel, Gisele A; University of São Paulo. School of Pharmaceutical Sciences of Ribeirão Preto. Department of Physics and Chemistry. Ribeirão Preto. Brasil
  • Bordon, Karla C. F; University of São Paulo. School of Pharmaceutical Sciences of Ribeirão Preto. Department of Physics and Chemistry. Ribeirão Preto. Brasil
  • Silva, Ronivaldo R; Universidade Estadual Paulista. Institute of Biosciences, Letters and Exact Sciences. São José do Rio Preto. Brasil
  • Gomes, Mário S. R; Federal University of Uberlândia. Institute of Genetics and Biochemistry. Uberlândia. Brasil
  • Cabral, Hamilton; University of São Paulo. School of Pharmaceutical Sciences of Ribeirão Preto. Department of Pharmaceutical Sciences. Ribeirão Preto. Brasil
  • Rodrigues, Veridiana M; Federal University of Uberlândia. Institute of Genetics and Biochemistry. Uberlândia. Brasil
  • Ueberheide, Beatrix; New York University Langone Medical Center. Proteomics Resource Center. New York. Estados Unidos
  • Arantes, Eliane C; University of São Paulo. School of Pharmaceutical Sciences of Ribeirão Preto. Department of Physics and Chemistry. Ribeirão Preto. Brasil
J. Venom. Anim. Toxins incl. Trop. Dis. ; 25: e147018, Apr. 15, 2019. tab, graf
Article em En | VETINDEX | ID: vti-19286
Biblioteca responsável: BR68.1
ABSTRACT

Background:

Lachesis muta rhombeata is one of the venomous snakes of medical importance in Brazil whose envenoming is characterized by local and systemic effects which may produce even shock and death. Its venom is mainly comprised of serine and metalloproteinases, phospholipases A2 and bradykinin-potentiating peptides. Based on a previously reported fractionation of L. m. rhombeata venom (LmrV), we decided to perform a subproteome analysis of its major fraction and investigated a novel component present in this venom.

Methods:

LmrV was fractionated through molecular exclusion chromatography and the main fraction (S5) was submitted to fibrinogenolytic activity assay and fractionated by reversed-phase chromatography. The N-terminal sequences of the subfractions eluted from reversed-phase chromatography were determined by automated Edman degradation. Enzyme activity of LmrSP-4 was evaluated upon chromogenic substrates for thrombin (S-2238), plasma kallikrein (S-2302), plasmin and streptokinase-activated plasminogen (S-2251) and Factor Xa (S-2222) and upon fibrinogen. All assays were carried out in the presence or absence of possible inhibitors. The fluorescence resonance energy transfer substrate Abz-KLRSSKQ-EDDnp was used to determine the optimal conditions for LmrSP-4 activity. Molecular mass of LmrSP-4 was determined by MALDI-TOF and digested peptides after trypsin and Glu-C treatments were analyzed by high resolution MS/MS using different fragmentation modes.

Results:

Fraction S5 showed strong proteolytic activity upon fibrinogen. Its fractionation by reversed-phase chromatography gave rise to 6 main fractions (S5C1-S5C6). S5C1-S5C5 fractions correspond to serine proteinases whereas S5C6 represents a C-type lectin. S5C4 (named LmrSP-4) had its N-terminal determined by Edman degradation up to the 53rd amino acid residue and was chosen for characterization studies. LmrSP-4 is a fibrinogenolytic...(AU)
Palavras-chave